IRCCS Ospedale San Raffaele
Milan, 20132, Italy
Location contact
Luigi Albano, MD, PhD
CONTACT
0226435568 ext. +39
Luigi Albano, MD, PhD
PRINCIPAL_INVESTIGATOR
Pietro Mortini, MD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07412808
Interventional prospective longitudinal on the evaluation of spinal cord stimulation (SCS) assisted by motor rehabilitation training for restoring motor function in patients with non-traumatic spinal cord injury (SCI). The investigators will enroll ten research participants with clinically incomplete/complete SCI (patients with paraplegia or severe paraparesis) who will undergo SCS subsequently assisted by motor rehabilitation training for restoring motor function at IRCCS Ospedale San Raffaele, Milan, Italy. The main goal of the project is to evaluate the improvement in motor function generated by the combination of SCS and locomotor training. In line with recently published studies, the investigators propose that daily locomotor training in the presence of SCS with continuous stimulation parameters setting will enable the SCI individuals to stand and step independently while bearing full weight.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Milan, 20132, Italy
Luigi Albano, MD, PhD
CONTACT
0226435568 ext. +39
Luigi Albano, MD, PhD
PRINCIPAL_INVESTIGATOR
Pietro Mortini, MD
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The first part of the study will involve a preoperative evaluation. Participants' clinical history, neurological, neurophysiological and advanced brain/spine MRI examination will be assessed (Part 1). Subsequently, participants will undergo spinal cord stimulation surgery which involves the implantation of a medical device (Part 2). After the surgery, the research participants will be hospitalized at the Neurosurgery Unit (5-14 days) to monitor the incision site (Part 3). Thereafter, the patients will be moved (for at least 6 weeks) to the Rehabilitation Unit in order to identify appropriate stimulation parameters for inducing stepping and standing and for starting training. The combination of epidural stimulation with manual step/stand training will be thus evaluated (Part 4). Patients will be finally assessed by clinical evaluation, advanced MRI and neurophysiological examination to study the brain, spine and peripheral functions after six months (Part 5).
Time frame: Before surgery, then monthly up to 6-month from surgery
The Medical Research Council's (MRC) scale of muscle power will be used to evaluate motor weakness. The MRC scale of muscle strength uses a score from Grade 5 (normal) to Grade 0 (no visible contraction) to assess the power of a particular muscle group in relation to the movement of a single joint.
Time frame: Before surgery, then monthly up to 6-month from surgery
The Lower Extremity Functional Scale (LEFS) will be used by clinicians as a measure of lower extremity function. It is a questionnaire containing 20 questions about a person's ability to perform everyday tasks (minimum score 0, maximum score 80).
Time frame: Before surgery, then monthly up to 6-month from surgery
The Modified Ashworth scale will be used to evaluate spasticity. This scale grades the muscle tone from 0 (normal) to 4 (severe spasticity).
Time frame: Before surgery and 6 months after procedure
Electromyography will be used to evaluate muscle response or electrical activity in response to a nerve's stimulation.
Time frame: Before surgery and 6 months after procedure
Motor evoked potentials will be used to evaluate electrical signals recorded from the descending motor pathways or from muscles following stimulation of motor pathways within the brain.
Time frame: Before surgery and 6 months after procedure
Sensory evoked potentials will be used to assess electrical activity in the brain in response to sensory stimulation.
Time frame: Before surgery and 6 months after procedure
Structural and functional brain and spine MRI analysis.
Time frame: Before surgery and 6 months after procedure
The McGill Pain Questionnaire (MPQ) can be used to evaluate a person experiencing significant pain. It consists of 15 descriptors (11 sensory; 4 affective) which are rated on an intensity scale as 0 = none, 1 = mild, 2 = moderate or 3 = severe.
Time frame: Before surgery and 6 months after procedure
The Pain Catastrophizing Scale (PCS) assesses the extent of catastrophic thinking. It assesses the extent of catastrophic thinking due to low back pain according to 3 components: rumination, magnification, and helplessness. It is a 13-item scale, with a total range of 0 to 52. Higher scores are associated with higher amounts of pain catastrophizing.
Time frame: Before surgery and 6 months after procedure
12-item Allodynia Symptom Checklist (ASC-12) evaluates presence of allodynia and hypoesthesia.
Albano Luigi
Other
Evaluation of Spinal Cord Stimulation Assisted by Motor Rehabilitation Training for Restoring Motor Function in Non-traumatic Spinal Cord Injury: an Interventional, Prospective, Monocentric Study
Acronym: Neuro-scs-002
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07430904
Central Nervous System Diseases, Female Urogenital Diseases
Houston, Texas, United States
View Trial DetailsNCT06981338
Central Nervous System Diseases, Nervous System Diseases
Badalona, Barcelona, Catalonia, Spain
View Trial DetailsNCT06698224
Central Nervous System Diseases, Nervous System Diseases
West Orange, New Jersey, United States
View Trial DetailsNCT07364773
Central Nervous System Diseases, Nervous System Diseases
Chicago, Illinois, United States
View Trial Details